disopyramide has been researched along with cifenline in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (10.00) | 18.7374 |
| 1990's | 12 (40.00) | 18.2507 |
| 2000's | 10 (33.33) | 29.6817 |
| 2010's | 5 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Du, LP; Li, MY; Tsai, KC; Xia, L; You, QD | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Hayashi, S; Horie, M; Sasayama, S; Yuzuki, Y | 1 |
| Arita, M; Kiyosue, T; Sato, T; Wu, B | 1 |
| Boucher, M; Cazes, M; Chassaing, C; Cloarec, A; Duchêne-Marullaz, P; Martinet, M; Provost, D | 1 |
| Hashimoto, H; Nakashima, M; Satoh, N | 1 |
| Hasegawa, J; Hirokane, Y; Kotake, H; Mashiba, H; Nawada, T; Noguchi, N | 1 |
| Somberg, J | 1 |
| Furuya, H; Goto, Y; Tanabe, T; Yoshikawa, H | 1 |
| Hamada, E; Hazama, H; Iwasawa, K; Kurachi, Y; Nakajima, T; Omata, M; Wu, SN; Yamashita, T | 1 |
| Lüderitz, B; Manz, M | 1 |
| Aizawa, Y; Chinushi, M; Naitoh, N; Shibata, A | 1 |
| Fujiki, A; Inoue, H; Tani, M; Yoshida, S | 1 |
| Beurrier, D; Brembilla-Perrot, B; Danchin, N; Houplon, P; Jacquemin, L; Louis, P; Terrier de la Chaise, A | 1 |
| Ajiki, K; Murakawa, Y; Omata, M; Sezaki, K; Yamashita, T | 1 |
| Aizawa, Y; Tanabe, Y; Yamaura, M | 1 |
| Baudouy, Y; Bine-Scheck, F; Cheikel, J; Dambrine, P; Flammang, D; Graux, P; Jouannon, C; Leenhardt, A; Piot, O | 1 |
| Fujita, S; Harano, Y; Katayama, Y; Shibakawa, M; Takada, M | 1 |
| Aye, NN; Hashimoto, K; Miyamoto, S; Teramatsu, T; Zhu, B | 1 |
| Satoh, H | 1 |
| Imai, H; Matoba, Y; Nakagawa, M; Shiraishi, H; Shirayama, T; Yoshida, S | 1 |
| Abe, N; Horiuchi, D; Kameda, K; Komatsu, T; Nakamura, S; Oikawa, K; Okumura, K; Owada, S; Suzuki, O; Tomita, H; Yomogida, K | 1 |
| Abe, A; Ikeda, T; Ishiguro, H; Mera, H; Miwa, Y; Miyakoshi, M; Sakaki, K; Tsukada, T; Yoshino, H; Yusu, S | 1 |
| Komatsu, T; Kunugita, F; Nakamura, M; Okabayashi, H; Ozawa, M; Satoh, Y; Tachibana, H; Tashiro, A | 1 |
| Imai, T; Kajimoto, K; Kasanuki, H; Minami, Y | 1 |
| Hamada, M; Ikeda, S; Shigematsu, Y | 1 |
4 review(s) available for disopyramide and cifenline
| Article | Year |
|---|---|
Antiarrhythmic drug therapy. Recent advances and current status.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Disopyramide; Drug Administration Schedule; Encainide; Flecainide; Heart Conduction System; Humans; Imidazoles; Lidocaine; Mexiletine; Moricizine; Myocardial Contraction; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tocainide; Verapamil | 1985 |
Supraventricular tachycardia and pre-excitation syndromes: pharmacological therapy.
Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Disopyramide; Flecainide; Humans; Imidazoles; Pre-Excitation Syndromes; Propafenone; Quinidine; Sotalol; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Verapamil | 1993 |
Reentrant ventricular tachycardia. Interpretations of electrophysiologic findings and its applications.
Topics: Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Cardiomyopathies; Disopyramide; Electrocardiography; Electrophysiology; Heart Conduction System; Humans; Imidazoles; Mexiletine; Procainamide; Tachycardia, Ventricular | 1998 |
Advances in medical treatment of hypertrophic cardiomyopathy.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Anti-Arrhythmia Agents; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic, Familial; Death, Sudden, Cardiac; Diastole; Disease Progression; Disopyramide; Female; Heart Failure; Humans; Imidazoles; Male; Middle Aged; Systole; Ventricular Dysfunction, Left; Ventricular Remodeling | 2014 |
4 trial(s) available for disopyramide and cifenline
| Article | Year |
|---|---|
Electrophysiologic mechanisms of adverse effects of class I antiarrhythmic drugs (cibenzoline, pilsicainide, disopyramide, procainamide) in induction of atrioventricular re-entrant tachycardia.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Disopyramide; Electrophysiology; Female; Heart Conduction System; Humans; Imidazoles; Lidocaine; Male; Middle Aged; Procainamide; Tachycardia, Atrioventricular Nodal Reentry; Wolff-Parkinson-White Syndrome | 1996 |
Ostensible day-night difference of QT prolongation during long-term treatment with antiarrhythmic drugs: reappraisal of the law of "regression to the mean".
Topics: Anti-Arrhythmia Agents; Circadian Rhythm; Data Interpretation, Statistical; Disopyramide; Electrocardiography; Female; Heart Rate; Humans; Imidazoles; Male; Middle Aged | 1998 |
[A randomized double-blind trial comparing cibenzoline and disopyramide in the prevention of recurrences of atrial tachyarrhythmia].
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Disopyramide; Double-Blind Method; Female; Humans; Imidazoles; Male; Middle Aged; Recurrence; Tachycardia | 1998 |
Prospective comparative study of intravenous cibenzoline and disopyramide therapy in the treatment of paroxysmal atrial fibrillation after cardiovascular surgery.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiovascular Surgical Procedures; Disopyramide; Female; Heart Atria; Humans; Imidazoles; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2010 |
22 other study(ies) available for disopyramide and cifenline
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents.
Topics: Anti-Arrhythmia Agents; Models, Biological; Models, Molecular; Potassium Channel Blockers; Potassium Channels; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparative studies of ATP sensitive potassium channels in heart and pancreatic beta cells using Vaughan-Williams class Ia antiarrhythmics.
Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Disopyramide; Dose-Response Relationship, Drug; Imidazoles; Islets of Langerhans; Membrane Potentials; Myocardium; Potassium Channels; Rats; Rats, Wistar | 1992 |
Blockade of 2,4-dinitrophenol induced ATP sensitive potassium current in guinea pig ventricular myocytes by class I antiarrhythmic drugs.
Topics: 2,4-Dinitrophenol; Action Potentials; Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Dinitrophenols; Disopyramide; Flecainide; Glyburide; Guinea Pigs; Heart Ventricles; Imidazoles; Lidocaine; Mexiletine; Myocardium; Piperidines; Potassium; Procainamide; Pyridines | 1992 |
Comparison of anticholinergic effects of cibenzoline, disopyramide, and atropine.
Topics: Animals; Atropine; Brain; Cerebral Cortex; Disopyramide; Dogs; Electric Stimulation; Female; Heart; Heart Rate; Imidazoles; In Vitro Techniques; Infusions, Intravenous; Injections, Intravenous; Male; Membranes; Myocardium; Parasympatholytics; Rats; Rats, Inbred Strains; Vagus Nerve | 1990 |
Coupling interval-related effects of class I antiarrhythmic drugs, mexiletine, cibenzoline and disopyramide, on ventricular activation in canine myocardial infarction.
Topics: Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Disopyramide; Dogs; Electric Stimulation; Electrocardiography; Heart Rate; Imidazoles; Injections, Intravenous; Mexiletine; Myocardial Infarction; Ventricular Function, Right | 1991 |
Transient increase in the contractile force induced by antiarrhythmic drugs in guinea pig cardiac muscles.
Topics: Animals; Anti-Arrhythmia Agents; Aprindine; Disopyramide; Guinea Pigs; Imidazoles; In Vitro Techniques; Myocardial Contraction; Quinidine | 1989 |
Therapeutic effectiveness and plasma levels of single or combination use of class I antiarrhythmic agents for ventricular arrhythmias.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Chronic Disease; Disopyramide; Drug Therapy, Combination; Female; Heart Ventricles; Humans; Imidazoles; Male; Mexiletine; Middle Aged | 1988 |
Molecular mechanism of cibenzoline-induced anticholinergic action in single atrial myocytes: comparison with effect of disopyramide.
Topics: Animals; Disopyramide; Guinea Pigs; Heart Atria; Imidazoles; In Vitro Techniques; Parasympatholytics; Potassium Channels; Receptors, Muscarinic; Receptors, Purinergic P1 | 1994 |
Drug-induced narrowing of the width of the zone of entrainment as a predictor of the subsequent non-inducibility of reentrant ventricular tachycardia after an additional dose of an antiarrhythmic drug.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Disopyramide; Drug Administration Schedule; Electrocardiography; Female; Heart; Humans; Imidazoles; Male; Mexiletine; Middle Aged; Procainamide; Tachycardia, Ventricular | 1996 |
[Can 1/1 atrial flutter be foreseen by class I anti-arrhythmics?].
Topics: Aged; Anti-Arrhythmia Agents; Atrial Flutter; Disopyramide; Electrocardiography; Female; Flecainide; Heart Conduction System; Humans; Imidazoles; Male; Middle Aged; Predictive Value of Tests; Propafenone; Quinidine; Risk Factors | 1997 |
The relationship between risk of hypoglycemia and use of cibenzoline and disopyramide.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Blood Glucose; Case-Control Studies; Disopyramide; Fasting; Female; Humans; Hypoglycemia; Imidazoles; Logistic Models; Male; Middle Aged; Potassium Channel Blockers; Sulfonylurea Compounds | 2000 |
QT-prolonging class I drug, disopyramide, does not aggravate but suppresses adrenaline-induced arrhythmias. Comparison with cibenzoline and pilsicainide.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Disopyramide; Dogs; Drug Interactions; Electrocardiography; Epinephrine; Female; Heart Rate; Imidazoles; Lidocaine; Male | 2000 |
Comparative actions of cibenzoline and disopyramide on I(Kr) and I(Ks) currents in rat sino-atrial nodal cells.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Disopyramide; Imidazoles; Ion Channels; Rabbits; Rats; Rats, Wistar; Sinoatrial Node | 2000 |
Atrial fibrillation threshold predicted long-term efficacy of pharmacological treatment of patients without structural heart disease.
Topics: Aged; Anti-Arrhythmia Agents; Aprindine; Atrial Fibrillation; Disopyramide; Electrophysiologic Techniques, Cardiac; Female; Flecainide; Humans; Imidazoles; Lidocaine; Male; Middle Aged; Treatment Outcome | 2002 |
[Comparison of the efficacies of disopyramide, cibenzoline and aprindine for the termination of paroxysmal and persistent atrial fibrillation in elderly and non-elderly patients].
Topics: Aged; Anti-Arrhythmia Agents; Aprindine; Atrial Fibrillation; Autonomic Nervous System; Circadian Rhythm; Disopyramide; Female; Humans; Imidazoles; Male; Middle Aged | 2003 |
Quantitative assessment of cibenzoline administration for vagally mediated paroxysmal atrial fibrillation using frequency-domain heart rate variability analysis.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Cholinergic Antagonists; Disopyramide; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Imidazoles; Male; Middle Aged; Treatment Outcome | 2009 |
Comparison of acute reduction in left ventricular outflow tract pressure gradient in obstructive hypertrophic cardiomyopathy by disopyramide versus pilsicainide versus cibenzoline.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Disopyramide; Echocardiography, Doppler; Female; Humans; Imidazoles; Lidocaine; Linear Models; Male; Middle Aged; Propranolol; Prospective Studies; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Pressure; Verapamil | 2010 |